association between sex differences and the pharmacokinetics of repaglinide among a malaysian population性别差异之间的关联、repaglinide在马来西亚人口的药物动力学.pdfVIP

association between sex differences and the pharmacokinetics of repaglinide among a malaysian population性别差异之间的关联、repaglinide在马来西亚人口的药物动力学.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
association between sex differences and the pharmacokinetics of repaglinide among a malaysian population性别差异之间的关联、repaglinide在马来西亚人口的药物动力学

Pharmacology Pharmacy, 2011, 2, 332-337 doi:10.4236/pp.2011.24042 Published Online October 2011 (http://www.SciRP.org/journal/pp) Association between Sex Differences and the Pharmacokinetics of Repaglinide among a Malaysian Population 1* 1 2 3 Ruzilawati Abu Bakar , Mohd Suhaimi Ab Wahab , Imran Ahmad , Gan Siew Hua 1Department of Pharmacology, Universiti Sains Malaysia, Kota Bharu, Malaysia; 2Department of Family Medicine, Universiti Sains Malaysia, Kota Bharu, Malaysia; 3Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Ma- laysia. * Email: tieimran@ Received April 28th, 2011; revised May 20th, 2011; accepted June 25th, 2011. ABSTRACT This study was conducted to evaluate the effect of sex differences on the pharmacokinetics of repaglinide in healthy subjects. One hundred twenty one healthy volunteers (61 male and 60 female; aged 18 - 50 years) were included in the study. Subjects were administered a single 4-mg repaglinide oral dose. Blood samples were taken at 0, 30, 60, 120, 180 and 240 min. Serum repaglinide levels were determined by a high-performance liquid chromatography (HPLC) method. Subjects were also genotyped by polymerase chain reactions-restriction fragment length polymorphisms (PCR-RFLP) for CYP 3A4*4, *5 and *18 alleles and by an allele-specific multiplex PCR for CYP2C8*2, *3, *4 and *5 alleles. The pharmacokinetics of repaglinide were comparable betw een male and female subjects. The mean clearance (CL) of re- paglinide was 16.0% lower (p = 0.03), the mean area under the serum concentration-time curve (AUC) was 12.8% higher (p = 0.04) and the peak serum concentration (Cmax) was 13.2% higher (p = 0.03) in females compared to male subjects. The mean rate of elimination (kel) and mean CL of repaglinide were 47.67% (p = 0.03) hig

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档